Dr. Toni Choueiri, ESMO (IMAGE)

European Society for Medical Oncology

Dr. Toni Choueiri, ESMO

Caption

The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic kidney cancer. The late breaking results are presented at ESMO 2020.

Credit

Copyright ESMO

Usage Restrictions

Picture can be used only for this press release

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.